Eric Gordon MD

Eric Gordon MD is the founder and medical director of Gordon Medical Associates in Santa Rosa, California. Dr. Gordon searches out the newest and the best of medical treatments in his quest to help patients that much of the rest of medicine ignores. For Dr. Gordon, however, knowledge and understanding does not come primarily from research, but from interaction and direct experience with his patients. He is first and foremost a private practice physician. His deep respect for the biochemical individuality of his patients is at the heart of his approach.


Eric Gordon and Nafysa Parpia to Speak at American Academy of Ozonotherapy

2017 AAO Annual Meeting

From the AAO website: What Is Ozone Therapy? Ozonotherapy is the use of medical grade ozone, a highly reactive form of pure oxygen, to create a curative response in the body. The body has the potential to renew and regenerate itself. When it becomes sick it is because this potential has been blocked. The reactive properties of ozone stimulate the body to remove many of these impediments thus allowing the body to do what it does best – heal itself. [Read more…]


Update on SISOH Metabolomics Research 4/6/17

Eric Gordon MD and Wayne Anderson ND at SISOH

Eric Gordon MD and Wayne Anderson ND – photo courtesy of the Press Democrat, Christopher Chung

From Eric Gordon, MD

Many of you are probably wondering where we are with the SISOH research. Good news is that Kelly Fox, previously one of the Medical Assistants at GMA, has come on as a full-time Research Coordinator! Kelly is very experienced in working with chronically ill patients, and we think you will find her a delight to work with.

Our ongoing CFS/ME studies are group studies working to develop an accepted group of biomarkers to define people with CFS/ME. We have enrolled all the patients in the replication study with Dr. Cheney, and hope to publish that in fall of 2017. [Read more…]


Press Democrat: Santa Rosa doctor’s study offers new insight into chronic fatigue syndrome

THE PRESS DEMOCRAT | September 21, 2016

Eric Gordon MDA new study initiated by (Eric) Gordon and including Harrison as one of the subjects could provide that breakthrough.

The study, published last month, detected a “chemical signature” in the blood of chronic fatigue syndrome patients, establishing for the first time that chronic fatigue syndrome is an “objective metabolic disorder,” said co-author Dr. Robert Naviaux, the UC San Diego researcher who identified the blood chemical anomalies associated with the condition.

Gordon is a co-author of the study, and most of the patients in the study came from his practice.

Read PD Article

Read Full Study Paper


Ron Davis’ response to the NIH Request For Information (RFI): Input for New Research Strategies for ME/CFS

Dr. Ron Davis kindly gave us permission to post his letter on the blog:

We are grateful for the opportunity to provide input to the Trans-National Institutes of Health (NIH) ME/CFS Working Group as they develop strategies to guide NIH’s research efforts and priority setting for research on ME/CFS. Our mission at the Stanford Chronic Fatigue Syndrome Research Center is to discover causes, a molecular diagnosis, and treatment options for ME/CFS. Through our research efforts, collaborations with the ME/CFS research and clinical community, and extensive engagement with patients, we have defined several elements of importance for future ME/CFS research programs.

A key consideration in ME/CFS research efforts is the complex and multisystemic nature of this disease, [Read more…]


Gordon Medical Research Center Now Funding Replication Study on CFIDS/ME Findings

Eric Gordon MDBy Eric Gordon, MD

The collaboration of an innovative medical practice with a university research center has been my lifelong dream.  Combining forces with Dr. Robert Naviaux and his research into metabolomics, mitochondrial function, and chronic inflammatory disease is now bringing this dream to life.

The opening of the Gordon Medical Research Center is a critical element in developing funding for the research into the complex illnesses we focus on. Your donation will make possible further research into metabolomics and mitochondrial function and their impact on health and illness. Illnesses potentially caused by mitochondrial dysfunction will ultimately affect over 50% of the people born today. These diseases include autoimmune diseases, autism, Myalgic Encephalopathy/Chronic Fatigue Syndrome  (ME/CFS), Post-Traumatic Stress Disorder (PTSD), Gulf War Illness,  diabetes, heart disease, certain mental health disorders, and cancer.

Eric Gordon, MD
Founder, Gordon Medical Associates
Science in Service of Humanity
Gordon Medical Research Center
Funding Research For Poorly Defined and Undiagnosed Chronic Illness

Dr. Robert Naviaux and I have submitted for publication a study, now under peer review and expected to be published in the fall of 2016, [Read more…]


Patient Powered Research into Lyme Disease

We recommend that you look into the research being done by through MyLymeData. Being able to collect information from thousands of Lyme patients has the potential to open up new avenues of Lyme disease research. Watch the video, and then go to the website to learn more, and sign up to participate!

Imagine a world where people with Lyme disease are diagnosed and treated correctly and go back to living their lives.

Add your Lyme data to MyLymeData
to help find a cure for Lyme disease.

MyLymeData is a patient-powered research project. It was conceived by patients, is run by patients, and addresses the issues that patients care about. It lets Lyme disease patients learn from each other and provides data that can help drive research to improve their lives.


Did you ever think it would be possible to significantly decrease or even cure persistent pain without strong drugs or injections?



Change the Brain; Relieve the Pain; Transform the Person

Dr. Michael Moskowitz MD has developed a strategy called  “Neuroplastic Transformation” training the brain to change itself back to the healthy state that existed before persistent pain developed.  Neuroplastix is dedicated to curing the disease of persistent pain in all people who suffer by unifying brain and body as the focus of treatment.

The educational programs establish a new paradigm in pain care, bringing advances in neuroscience to anyone affected by persistent pain, including patients, their families and providers. This is accomplished via conferences, interactive materials, scientific publications and professional training, providing a method to transform the clinical treatment of pain.

For more information on Dr. Moskowitz go to

Join Dr. Moskowitz  in person and via webinar Wednesday May 11th 6:30 – 8:30 pm MDT and celebrate International Awareness Day for ME/CFS, FM and MCS.

To register go to:


The Future of Medicine and Health

The Cutting Edge of Health and Wellness Today
Friday, June 26, at 2 PM Pacific

The Future of Medicine and Health

I am delighted to be joined today by my friend and colleague Dr. Eric Gordon, founder of our clinic, Gordon Medical Associates. We will launch into a discussion of where we feel the future of medical care is going from a variety of perspectives. One particularly exciting new development is our work with Dr. Naviaux’s concept of the Cell Danger Response and how that work has the potential to change the way medicine is practiced.


Featured Guests
Eric Gordon MD
Eric imageDr. Eric Gordon is the founder and director of the Gordon Medical Associates, one of our country’s best respected alternative medical centers. Dr. Gordon has worked tirelessly to bring a wide variety of integrative medical practices under one roof so that patients will have the opportunity to be treated with the most comprehensive modalities currently available. Well known for his work with Lyme Disease, Fibromyalgia and Chronic Fatigue, Dr. Gordon is also known for his diagnostic abilities and breadth of knowledge.


Fluoride Danger to Children

SUNDAY APRIL 19, 2015:

William J. Hirzy, PhD will speak on fluoride danger to children.

Dr. Bill Hirzy (2015). Photo courtesy of Ellen Connett.

Dr. Bill Hirzy (2015). Photo courtesy of Ellen HIrzy.

Dr. Bill Hirzy, longtime top scientist for EPA Toxics Risk Assessment, will discuss the risks of fluoridated water to our children, followed by a Q & A session during which you can get answers to your questions direct from Dr. Hirzy.

Board Certified local physician Dr. April Hurley will be on hand in the lobby, before and after the presentation, to answer questions about fluoridated water from a medical viewpoint. You are invited to bring your friends and your questions.

[Read more…]



Published in Triton, a UC San Diego Alumni Publication

By Scott LaFee
Scott LaFee is a public information officer at UC San Diego Health Sciences.

Heart disease and cancer kill. Chronic conditions like diabetes and arthritis plague millions. Alzheimer’s disease robs the elderly of their memories. But none are more terrifying than autism, which afflicts children and whose symptoms, seeming to appear without warning between the ages of two and three, can dramatically erase a child’s previous development and personality. ..

“Autism has a different kind of history,” says Laura Schreibman, Ph.D., distinguished professor emeritus of psychology who founded the groundbreaking Autism Intervention Research Program at UC San Diego in 1984. “For example, cancer never started off with parents being blamed. People got defensive. We know a lot about cancer, but relatively little about autism, which can result in some very strange or wrong-headed ideas. It’s sad, confusing and unfortunate . . . But I’ve never felt there was a better career for me.”
Read full article


Robert NaviauxRobert Naviaux, M.D. ’86, Ph.D., is a relative newcomer to autism research.

A professor in the departments of Medicine, Pediatrics and Pathology, Naviaux is a highly regarded authority on mitochondria—the tiny power plants in all cells, whose dysfunction can result in an alarming array of metabolic diseases.

For decades, Naviaux and colleagues have pioneered genetic research in mitochondrial conditions. Some are well-known afflictions, such as diabetes, but others are not. Leigh’s disease, for example, is a rare inherited disorder that typically strikes without warning in a child’s first year of life, triggering seizures and rapid development regression. Patients rarely survive to adolescence.

Naviaux got seriously involved in autism research after being invited to a meeting of autism scientists. He listened, pondered and soon had the glimmerings of a new hypothesis. Different from classical forms of mitochondrial diseases, which are solely genetic, Naviaux concluded that autism was the result of multiple converging causes: genetic, environmental and a phenomenon dubbed the “cell danger response” (CDR).

The CDR hypothesis posits that when genes and environmental factors interact adversely, cells that feel threatened or become damaged react defensively. Their protective membranes stiffen. Internal metabolic processes change, most notably those involving mitochondria. Communications with other cells are dramatically reduced.

“Cells behave like countries at war,” Naviaux said. “When a threat begins, they harden their borders. They don’t trust their neighbors. But without constant communication with the outside, cells begin to function differently. In the case of neurons, it might be by making fewer or too many connections. One way to look at this related to autism is this: When cells stop talking to each other, children stop talking.”

Naviaux’s work pushes the limits of the prevailing autism paradigm, but he insists it is actually complementary. Autism results from genetics, environmental factors and dysfunctional metabolic processes.

In the last two years, he has published papers showing that when CDR is tamped down, allowing cells to restore normal communications and functions, autism-like symptoms in a mouse model are reversed.

The particular remedy uses a century-old drug for treating sleeping sickness. While its beneficial effects are temporary and adverse side effects make it unsuitable for long-term use, Naviaux thinks it could lead to new insights and therapies not yet imagined.

“We can only be observers and ask questions of nature. We can use the tools of the scientific method to test new ideas. We must have the courage to follow where the data leads us without bias.”

Read full article

From Eric Gordon, MD at Gordon Medical:

Gordon Medical  has just completed collecting the blood and urine samples on 40 patients with CFIDS/ME and 40 controls for a new study. In this study Dr Naviaux will apply the same technology he used in his study of autism to define the activation state of the cell danger response (CDR) in people with CFIDS/ME compared to people without symptoms. Treatment options will depend on the results and our ability to fund the next step in research. Treatments that are new require significant investment in not just the science but also in fulfilling governmental regulations designed to protect patients. We are hoping once we have our preliminary results back to begin raising money to pay for the next steps. Look for an upcoming post where we talk about CDR and metabolomics.

(The results are now in, the study is under review, and is expected to be published in fall of 2016. We are now raising funds for a replication study starting June 2016. See more at the website below. All sizes of donations are gratefully accepted.  Editor- 6/2/2016)